Human TSP2 ELISA Kit (FM-E100170)
search
  • Human TSP2 ELISA Kit (FM-E100170)

Human TSP2 ELISA Kit

Catalog # FM-E100170

Print

$649.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

156 - 10,000 pg/mL

Sensitivity

10.0 pg/mL

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample volume

100 µL final volume, dilution factor varies on samples.

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Human TSP2 standard: 2 vials

 2. One 96-well plate precoated with anti-Human TSP2 Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

9. Stop solution: 10 mL x1.

10. Washing solution (20x): 25 mL x1.

 

 

Background

 

Thrombospondin-2, also known as TSP-2 and THBS-2, is a member of the Thrombospondin family which includes Thrombospondin-1 and -2 constituting subgroup A and form disulfide-linked homotrimers, as well as Thrombospondin-3, -4, and -5/COMP (cartilage oligomeric matrix protein) compromising subgroup B and form homopentamers. The human Thrombospondin-2 is synthesized as a 1172 amino acid (aa) precursor that includes an 18 aa signal peptide, an N-terminal heparin-binding domain, an oligomerization motif, one vWF-C (von Willebrand factor type C) domain, three Thrombospondin type-1 repeats, three EGF-like repeats, seven Thrombospondin type-3 repeats, and a lectin-like Thrombospondin C-terminal globular domain. Human Thrombospondin-2 shares 88-90% aa sequence identity with bovine, mouse, and rat Thrombospondin-2.

Primarily, Thrombospondin-2 has been shown to counteract blood vessel growth. The three Thrombospondin type-1 domains inhibit VEGF-induced EC migration and vascular tube formation. In vivo, full length Thrombospondin-2 can block tumor angiogenesis and induce vascular EC apoptosis. Histidine-proline-rich glycoprotein (HPRG) prevents interaction of Thrombospondin-2 with another putative receptor, CD36, on macrophages and vascular EC. The activities of Thrombospondin-2 are regulated by a number of putative receptors. The heparin-binding domain of Thrombospondin-2 mediates interactions with several integrins including α3β1 and α6β1 on microvascular endothelial cells (EC), and integrin α4β1 on large blood vessel EC. Thrombospondin-2 may also interact directly with integrins via an RGD (Arg-Gly-Asp) sequence in the type-3 repeat region, or indirectly through C-terminal-binding to integrin-associated protein (IAP/CD47). A fragment from heparin-binding domain to vWF-C domain in Thrombospondin-2 promotes EC survival, proliferation, and chemotaxis. In the heart, Thrombospondin-2 may play a role in maintaining myocardial matrix integrity, and in the nervous system, it has been shown to promote synaptogenesis.

New